NO993997L - Anvendelse av 9,10-sekokolesta-5,7,10(19)-trien-1-3-diol, eller alfakalsidol - Google Patents

Anvendelse av 9,10-sekokolesta-5,7,10(19)-trien-1-3-diol, eller alfakalsidol

Info

Publication number
NO993997L
NO993997L NO993997A NO993997A NO993997L NO 993997 L NO993997 L NO 993997L NO 993997 A NO993997 A NO 993997A NO 993997 A NO993997 A NO 993997A NO 993997 L NO993997 L NO 993997L
Authority
NO
Norway
Prior art keywords
triene
diol
secokolesta
calcidol
alpha
Prior art date
Application number
NO993997A
Other languages
English (en)
Other versions
NO993997D0 (no
Inventor
Paul Trouillas
Original Assignee
Paul Trouillas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Paul Trouillas filed Critical Paul Trouillas
Publication of NO993997D0 publication Critical patent/NO993997D0/no
Publication of NO993997L publication Critical patent/NO993997L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Manufacture Of Tobacco Products (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

Anvendelse av 9,10-sekokolesta- 5,7,10(19)-trien-l,3-diol eller alfakalsidol for fremstilling av et medikament for behandling og/eller forebyggelse av faste cancere hos mennesker, spesielt lungecancere og hjernecancere. Den effektive dose varierer mellom 0,25 og 10 ng/dag en voksen person med vekt 60 kg.
NO993997A 1997-02-20 1999-08-19 Anvendelse av 9,10-sekokolesta-5,7,10(19)-trien-1-3-diol, eller alfakalsidol NO993997L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9702247A FR2759586B1 (fr) 1997-02-20 1997-02-20 Medicament de type anticancereux comportant au moins a titre de principe actif du 1-alpha hydroxycalciferol ou alfacalcidol
PCT/FR1998/000347 WO1998036754A1 (fr) 1997-02-20 1998-02-20 Utilisation du 9,10-secocholesta-5,7,10(19)-trien-1,3-ol, ou alfacalcidol

Publications (2)

Publication Number Publication Date
NO993997D0 NO993997D0 (no) 1999-08-19
NO993997L true NO993997L (no) 1999-10-19

Family

ID=9504159

Family Applications (1)

Application Number Title Priority Date Filing Date
NO993997A NO993997L (no) 1997-02-20 1999-08-19 Anvendelse av 9,10-sekokolesta-5,7,10(19)-trien-1-3-diol, eller alfakalsidol

Country Status (15)

Country Link
EP (1) EP0981350B1 (no)
JP (1) JP2001511818A (no)
KR (1) KR20000075514A (no)
CN (1) CN1248168A (no)
AT (1) ATE206306T1 (no)
AU (1) AU6505098A (no)
BR (1) BR9807592A (no)
CA (1) CA2282086A1 (no)
DE (1) DE69801907D1 (no)
FR (1) FR2759586B1 (no)
IL (1) IL131502A0 (no)
NO (1) NO993997L (no)
PL (1) PL335190A1 (no)
TR (1) TR199901998T2 (no)
WO (1) WO1998036754A1 (no)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004026811A (ja) * 2002-04-30 2004-01-29 Kiyoshi Hashizume ビタミンｄ３誘導体を含有する抗癌作用を増強させるための薬剤
GB201704909D0 (en) * 2017-03-28 2017-05-10 Ldn Pharma Ltd Cancer therapy

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57149224A (en) * 1981-03-13 1982-09-14 Chugai Pharmaceut Co Ltd Tumor-suppressing agent
IL110117A0 (en) * 1994-06-24 1994-10-07 Univ Ben Gurion Pharmaceutical compositions comprising vitamin-d analogs

Also Published As

Publication number Publication date
AU6505098A (en) 1998-09-09
BR9807592A (pt) 2000-02-22
EP0981350B1 (fr) 2001-10-04
PL335190A1 (en) 2000-04-10
DE69801907D1 (de) 2001-11-08
NO993997D0 (no) 1999-08-19
TR199901998T2 (xx) 1999-11-22
FR2759586A1 (fr) 1998-08-21
WO1998036754A1 (fr) 1998-08-27
CA2282086A1 (fr) 1998-08-27
KR20000075514A (ko) 2000-12-15
CN1248168A (zh) 2000-03-22
FR2759586B1 (fr) 2000-01-14
ATE206306T1 (de) 2001-10-15
JP2001511818A (ja) 2001-08-14
IL131502A0 (en) 2001-01-28
EP0981350A1 (fr) 2000-03-01

Similar Documents

Publication Publication Date Title
CS553490A3 (en) Transdermal therapeutic system
UA39158C2 (uk) Похідні n4-оксикарбоніл-5'-дезокси-5-фторцитидину та фармацевтичний препарат на їх основі
PL342078A1 (en) Inhibition of raf kinase using symmetrical and dissymmetrical substituted dimethylureas
AP9801392A0 (en) Concentrated antibody preparation.
HK1032759A1 (en) Apparatus for restoring the balance of the human body.
IL131010A (en) Aryl sulfonamides and analogues thereof, processes for their preparation and pharmaceutical compositions comprising them in the treatment of neurodegenerative diseases
UA43378C2 (uk) Композиція для лікування респіраторного дистрес-синдрому новонароджених та респіраторного дистрес-синдрому дорослих
DE3070189D1 (en) Medicament, particularly for the treatment of cholera, and pharmaceutical compositions containing it
WO1992012715A3 (en) The use of loperamide and related compounds for treatment of respiratory disease symptoms
ATE367808T1 (de) N-chlorphenylcarbamate enthaltendes arzneimittel sowie n-chlorphenylthiocarbamate zur hemmung des wachstums von viren
EP0676200A3 (fr) Utilisation de l'éliprodil et de ses énantiomères pour la préparation de médicaments utiles dans le traitement des neuropathies périphériques et des maladies neurodégénératives centrales.
EP0744176A3 (en) Methods for inhibiting bone loss
EP0592903A3 (en) Use of Ancrod in the manufacture of medications for the treatment of restenosis.
NL300083I1 (nl) 1-Beta-D-ribofuranosyl-1,2,4-triazool-3-carboxamide voor de bereiding van een geneesmiddel voor de medische behandeling van mensen.
DK0719276T3 (da) Ïstradiolestre med stærk oral virkning samt farmaceutiske præparater med indhold deraf
NO993997D0 (no) Anvendelse av 9,10-sekokolesta-5,7,10(19)-trien-1-3-diol, eller alfakalsidol
AU2379997A (en) Remedy for external application, and use of an oil-in-water emulsion for said remedy
AU1898792A (en) Treatment or therapeutic booth for energetic, cosmetic and medical purposes
ZA893310B (en) Novel strobilurine derivatives,their preparation and their use
SE8704471D0 (sv) Solarium
MY114109A (en) The use of bioassimilable boron compounds
AU6819898A (en) Oxygen anion radicals and/or therapeutic preparations containing their reaction or breakdown products, and use of such preparations in the treatment of parkinson's disease
Chiyotani Stone Flakes, Human Beings and Clinical Medicine
ZA897549B (en) Medicament for the treatment of diseases caused by retroviruses
ATE74767T1 (de) Arzneimittelzusammensetzung zur behandlung des lungenverstopfens.